We are at an unprecedented moment in the field of melanoma. Since MRA was founded in 2007, 11 new treatments have expanded the arsenal of FDA-approved treatment options.
Today, only 1 out of 20 cancer patients enroll in a clinical trial. For melanoma patients, while therapies have improved dramatically, we’re far from a cure for all patients. Clinical trials offer patients access to treatment approaches that may prove more beneficial than anything currently approved by the FDA. In addition, clinical trials drive our understanding of melanoma forward, improving future treatment options for all patients. Lack of enrollment in clinical trials is one of the biggest obstacles to bringing new therapies to market and today there are more than 300 melanoma-focused clinical trials currently recruiting patients.
If you’re ready to start searching for the trial that best suits your needs, use our interactive clinical trial navigator below. Or, if you still have questions, we have created resources to help explain what clinical trials are and how they work, who can participate and what you can expect, benefits and risks, patient success stories, questions to ask your doctor, and answers to frequently asked questions.
Find a Melanoma Clinical Trial Here:
Read more about whether a clinical trial is right for you on our blog or join the conversation on the Melanoma > Exchange, our online community focused on melanoma research, clinical trials, and treatment.